Unit 1

Conquering of incurable diseases using stem cell-treatment technology

Ophthalmologic diseases

  • Development of patient-derived somatic cell nuclear transfer (SCNT) stem cell therapeutic agent for degenerative retinal disease patients
  • Development of placental stem cell therapeutic agent for traumatic optic nerve disease

Musculoskeletal diseases

  • Development of mesenchymal stem cell treatment technology for spinal functional improvement of degenerated intervertebral disc patients
  • Development of adipose tissue-derived stem cell treatment technology for arthritis patients
  • Development of adipose tissue-derived stem cell treatment technology for cartilage injury

Neurological diseases

  • Development of embryo-derived neural precursor cell transplantation technology for Parkinson’s disease
  • Development of umbilical cord-derived mesenchymal stem cell treatment technology for ischemic stroke
  • Development of combined allogeneic umbilical cord blood and erythropoietin treatment technology for cerebral palsy
  • Development of placenta-derived mesenchymal stem cell treatment technology for Alzheimer disease
  • Development of placenta-derived mesenchymal stem cell treatment technology for brain damage after cardiac arrest

Unit 2

Developing and commercializing of diagnostic/therapeutic technologies for the prevalent diseases of next generation

Infertility

  • Discovery of premature ovarian failure-related causative genomic changes, and development of new diagnostic and treatment technology for premature ovarian failure
  • Development of allogeneic umbilical cord stem cell therapeutic agent for Asherman’s syndrome

Aging

  • Premature aging mechanism-related biomarker research and anti-aging treatment target research for chronic renal insufficiency patients
  • Development of in vitro model of dermatologic aging and high speed mass screening technology of anti-aging material /blood vessel-inclusive artificial skin development

Cancer

  • Development of cancer gene therapeutic agent using cancer cell-specific killer virus vector
  • Development of targeted therapy for cancer stem cells/Investigation of immune therapy resistance mechanism and biomarker research
  • Chemoquiescence through seletive elimination of cancer stem cells and Clinical implementation of stem cell-based chemoprevention (siTRP strategy)
  • Development of diagnostic kits and theranostics for ovarian cancer therapeutic response prediction using chemoresistant ovarian cancer-specific biomarker